Though the biological mechanism(s) behind the observed favorable clinical outcomes of these two virally associated head and neck cancers remains largely unknown, plausible mechanisms may include the presence of wildtype TP53, and likely immunogenic viral antigens in these cancers. The gene discussed is TP53; the disease is cancer.